We enrolled 284 patients with KD from our search database in this study. We randomly and retrospectively included 156 KD patients with CAL formation and 126 age-matched KD patients without CAL formation as the control group. The percentage of males was higher in the CAL present group (77% vs. 54.0%, p<0.001) than the CAL absent group. We found no statistical differences in age for KD between the two groups (due to this being an age-matched case control study). The median age of these patients upon diagnosis of acute KD was 1.21 years and 1.31 years (p=0.318), respectively (Table 1).
Table 1 Characteristics of Participants, N=284
|
|
CAL Present group N=158
|
CAL Absent group N=126
|
p-value
|
Age, y
Mean (SD)
Median (IQR)
Youngest
Oldest
|
1.71(1.55)
1.21(1.60)
0.21
9.25
|
1.70(1.26)
1.31(1.46)
0.25
6.83
|
0.318
|
Gender, N(%)
Boy
Girl
|
121(77)
37(23)
|
68(54)
58(46)
|
<0.001
|
IVIG responder, N(%)
IVIG resistance, N(%)
|
129(82)
26(16)
|
119(94)
7(6)
|
0.004
|
The initial absolute values of the complete blood count, differential count, and CRP, as well as the liver function and albumin concentrations, in each group are provided in Table 2. We found WBC to be higher in the CAL present group than in the CAL absent group (13400 vs. 12700/mm3, p=0.021), the neutrophil count to be higher in the CAL present group (8.99±4.55 vs. 7.68±4.00 x1000/mm3, p=0.019) than in the CAL absent group, the platelet count to be higher in the CAL present group (386.88±160.24 vs. 324.39±99.92 x103/mm3), p<0.001) than in the CAL absent group, the CRP levels to have no significant difference between the CAL present group (91.98±76.51 vs. 85.53±75.61 mg/L, p=0.482) and the CAL absent group, and albumin levels to be significantly lower in the CAL present group (3.62±0.59 vs. 3.87±0.42 g/dL), p<0.001) than the CAL absent group.
Table 2 Baseline Laboratory Data comparison of the CAL present and the CAL absent groups on KD patients
|
Median (Q1-Q3)
|
|
CAL Present group N=158
|
CAL Absent group N=126
|
p-value
|
White blood cell count, 109L-1
Total
Seg.
Lym.
Mon.
Eos.
Bas.
|
13.4(10.5-18.2)
7.88(5.85-11.45)
3.72(2.41-5.13)
0.74(0.51-1.22)
0.35 (0.12-0.59)
0.01(0.00-0.04)
|
12.7(10.2-16.1)
7.05(5.04-10.17)
4.04 (3.11-5.16)
0.67(0.48-0.97)
0.29 (0.14-0.54)
0.00(0.00-0.03)
|
0.021*
0.019*
0.069
0.061
0.529
0.797
|
Hemoglobin, g/dL
|
11.1(10.1-11.6)
|
11.2(10.4-11.8)
|
0.208
|
Platelet count, 109L-1
|
359.5(291.8-450.3)
|
314.5(263.5-385.0)
|
<0.001*
|
CRP, mg/L
|
69.9(32.7-141.4)
|
63.2(30.3-113.6)
|
0.482
|
ALB, g/dL
|
3.7(3.3-4.0)
|
3.9(3.6-4.2)
|
<0.001*
|
ALT, U/L
|
37.0(21.0-120.8)
|
35.5(17.0-81.5)
|
0.124
|
AST, U/L
|
37.0(27.0-75.0)
|
33.5(27.0-64.0)
|
0.223
|
Furthermore, we found that prior to IVIG therapy, the CAL present group had a significantly higher segment-to-lymphocyte ratio (SLR) (3.48±3.97 vs. 2.32±2.19, P=0.002) and platelet-to-lymphocyte ratio (PLR) (127.92±93.37 vs. 91.09±53.47, P<0.001), while a significantly lower prognostic nutritional index (PNI) (55.92±13.86 vs. 59.63±10.21, P=0.023), than the CAL absent group, as shown in Table 3.
Table 3 Blood cell counts ratio and PNI comparison of the CAL present and the CAL absent groups on KD patients
|
Mean (SD)
|
|
CAL Present group N=158
|
CAL Absent group N=126
|
p-value
|
SLR
|
3.48(3.97)
|
2.32(2.19)
|
0.002
|
PLR
|
127.92(93.37)
|
91.09(53.47)
|
<0.001
|
PNI
|
55.92(13.86)
|
59.63(10.21)
|
0.023
|
The ROC curve analysis (Figure 1) indicates that the area under the ROC curve is 0.596 (0.522-0.670), with a significance 0.013 for PNI. The PNI cut-off value is determined to be 55.24 with a sensitivity of 0.509 and a specificity of 0.678 by maximizing the Youden’s index. In the following paragraph, we define the high-PNI group as PNI ≥ 55 and the low-PNI group as PNI < 55.
According to the multivariate analysis with logistic regression procedure (Table 4), the male gender, elevated platelet counts, and PNI-low group positively correlated with the presence of CAL. The risk of CAL formation was 2.827 greater in boys and 2.532 greater in the PNI-low group. The percentages of more than one instance of IVIG resistance in the low-PNI and high-PNI groups were 22.2% and 3.6% (p<0.001 with Pearson chi-square test), respectively.
Table 4 Univariate and multivariate analysis between the CAL present & CAL absent groups
|
|
Univariate
|
|
Multivariate
|
|
Estimator [95%CI]
|
p-value
|
|
Estimator [95%CI]
|
p-value
|
Gender, boy
|
2.789 (1.678-4.637)
|
<0.001
|
|
2.827 (1.556-5.134)
|
0.001
|
Age, y
|
1.007 (0.854-1.188)
|
0.931
|
|
|
|
Segment count, 109L-1
|
1.001 (1.000-1.001)
|
0.013
|
|
|
|
Platelets count, 109L-1
|
1.004 (1.002-1.006)
|
<0.001
|
|
1.004 (1.002-1.006)
|
0.001
|
Hemoglobin, g/dL
|
0.871 (0.699-1.086)
|
0.22
|
|
|
|
CRP, mg/L
|
1.001 (0.998-1.004)
|
0.48
|
|
|
|
Low-PNI (<55)
|
1.894 (1.105-3.247)
|
0.02
|
|
2.532 (1.394-4.599)
|
0.002
|
Under multivariate analysis, male gender, higher platelet count and lower PNI value (<55) before IVIG all had significantly positive correlation to CAL presence in 6 months of KD-illness.